{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:18:55Z","timestamp":1792063135402,"version":"4.4.0"},"reference-count":31,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2001,12,25]],"date-time":"2001-12-25T00:00:00Z","timestamp":1009238400000},"content-version":"vor","delay-in-days":1364,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[1998,4]]},"abstract":"<jats:p>The clinical significance of detecting minimal residual disease (MRD) in B\u2010lineage acute lymphoblastic leukaemia (ALL) was evaluated by quantitative flow cytometry using a combination of TdT with CD10 and CD19. 53 patients with B\u2010cell precursor ALL were followed during and after completion of treatment (median follow\u2010up 23 months). Nine patients relapsed and MRD had been detected in six of them, 5\u201315 weeks before relapse despite morphological complete remission. 43 patients remain in clinical remission and in none of these was MRD detected. Disease\u2010free survival based on the detection of MRD by flow cytometry showed a statistically significant difference between both groups (<jats:italic>P<\/jats:italic>\u2003&lt;\u20030.0001). The absence of MRD correlates with a low relapse rate, whereas the presence of MRD predicted early relapse. This study has shown that flow cytometry can improve the morphologic assessment of bone marrow (BM) remission status in B\u2010lineage ALL. The finding of &lt;\u20035% blasts in BM aspirates did not correlate with \u2018true\u2019 remission in a proportion of cases as residual leukaemic blasts were detected by flow cytometry in nine samples from six patients. On the other hand, the presence of &gt;\u20035% blasts assessed by morphology was not necessarily a feature of relapse in five patients as these cells were shown to have a phenotype identical to normal TdT\u2010negative B\u2010cell precursors. Quantitative flow cytometry was more informative than conventional morphology to assess remission status and showed a strong correlation with clinical outcome. This methodology is useful to define MRD in the majority of patients with B\u2010lineage ALL and should be tested in prospective clinical trials.<\/jats:p>","DOI":"10.1046\/j.1365-2141.1998.00675.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:00:29Z","timestamp":1047362429000},"page":"158-164","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Detection of minimal residual disease in B\u2010lineage acute lymphoblastic leukaemia by quantitative flow cytometry"],"prefix":"10.1111","volume":"101","author":[{"given":"Nahla","family":"Farahat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwasi","family":"Owusu\u2010Ankomah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Morilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Ross","family":"Pinkerton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennie G.","family":"Treleaven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estella","family":"Matutes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray L.","family":"Powles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Catovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"357","article-title":"Morphologic, immunologic and cytogenetic studies in children with acute lymphoblastic leukemia at diagnosis and relapse: a Pediatric Oncology Group study","volume":"6","author":"Abshire T.C.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_6_3_2","first-page":"305","article-title":"Flow cytometric determination of leukemia\u2010associated marker combinations for the study of minimal residual disease","volume":"41","author":"Babusikova O.","year":"1994","journal-title":"Neoplasma"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1981.tb02684.x"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02592442"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V76.1.163.163"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.6.1416.bloodjournal8561416"},{"key":"e_1_2_6_8_2","first-page":"609","article-title":"The detection of residual acute lymphoblastic leukemia cells with immunologic methods and polymerase chain reaction: a comparative study","volume":"4","author":"Campana D.","year":"1990","journal-title":"Leukemia"},{"key":"e_1_2_6_9_2","first-page":"1","article-title":"The classification of acute leukaemia","volume":"2","author":"Catovsky D.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_6_10_2","first-page":"853","article-title":"N\u2010CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia","volume":"7","author":"Coustan\u2010Smith E.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-3086-2_8"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990130813"},{"key":"e_1_2_6_13_2","first-page":"489","article-title":"Acute myeloid leukemias expressing lymphoid\u2010associated antigens: diagnostic incidence and prognostic significance","volume":"7","author":"Drexler H.G.","year":"1993","journal-title":"Leukemia"},{"key":"e_1_2_6_14_2","first-page":"583","article-title":"Differential TdT expression in acute leukemia by flow cytometry: a quantitative study","volume":"9","author":"Farahat N.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1995.tb05360.x"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)92766-0"},{"key":"e_1_2_6_17_2","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1182\/blood.V80.12.3182.3182","article-title":"Distinctive immunophenotypic features of t(8;21)(q22;q22) acute myeloblastic leukemia in children","volume":"80","author":"Hurwitz C.A.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(77)91515-X"},{"key":"e_1_2_6_19_2","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.4049\/jimmunol.123.4.1525","article-title":"Terminal transferase\u2010positive human bone marrow cells exhibit the antigenic phenotype of common acute lymphoblastic leukemia","volume":"123","author":"Janossy G.","year":"1979","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_20_2","first-page":"485","article-title":"Autologous bone marrow transplantation in acute lymphoblastic leukemia: preclinical immunologic studies","volume":"2","author":"Janossy G.","year":"1988","journal-title":"Leukemia"},{"key":"e_1_2_6_21_2","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1182\/blood.V76.10.2072.2072","article-title":"Detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin hypervariable region specific oligonucleotide probes","volume":"76","author":"Jonsson O.G.","year":"1990","journal-title":"Blood"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/cyto.990180404"},{"key":"e_1_2_6_23_2","first-page":"118","article-title":"Antigen density evaluation is a useful parameter in leukemia monitoring","volume":"13","author":"Lavabre\u2010Bertrand T.","year":"1994","journal-title":"Leukemia and Lymphoma"},{"key":"e_1_2_6_24_2","first-page":"166","article-title":"Possibilities and limitations of immunological marker analyses for the detection of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"13","author":"Ludwig W.D.","year":"1990","journal-title":"Onkologie"},{"key":"e_1_2_6_25_2","first-page":"993","article-title":"Immunological detection of blast cell subpopulations in acute myeloblastic leukemia at diagnosis: implications for minimal residual disease studies","volume":"9","author":"Macedo A.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_26_2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1182\/blood.V70.4.1073.1073","article-title":"Nonhomogeneous distribution of leukemia in the bone marrow during minimal residual disease","volume":"70","author":"Martens A.C.","year":"1987","journal-title":"Blood"},{"key":"e_1_2_6_27_2","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood.V82.5.1618.1618","article-title":"Long\u2010term follow\u2010up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction","volume":"82","author":"Nizet Y.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00441975"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.11.3083.3083"},{"key":"e_1_2_6_30_2","first-page":"47","article-title":"Detection of minimal residual disease in acute leukemia by immunological marker analysis and polymerase chain reaction","volume":"6","author":"Van Dongen J.J.","year":"1992","journal-title":"Leukemia"},{"key":"e_1_2_6_31_2","first-page":"1523","article-title":"Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia","volume":"9","author":"Van Wering E.R.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V77.2.331.331"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00675.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.1998.00675.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.1998.00675.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T11:33:40Z","timestamp":1694432020000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.1998.00675.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,4]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,4]]}},"alternative-id":["10.1046\/j.1365-2141.1998.00675.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.1998.00675.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,4]]},"assertion":[{"value":"2001-12-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}